Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human acute myeloid leukemia stem cells.

Kristin J Hope1, Liqing Jin, John E Dick

  • 1Division of Cell and Molecular Biology, University Health Network, and Department of Molecular Genetics and Microbiology, University of Toronto, Toronto, Ontario, Canada.

Archives of Medical Research
|January 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia.

Leukemia·2026
Same author

Ex vivo expansion of hematopoietic stem and progenitor cells from human mobilized peripheral blood for gene therapy applications.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Human haematopoietic stem cells remember inflammatory stress.

Nature·2026
Same author

ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Transposable elements shape stemness in normal and leukemic hematopoiesis.

Nature genetics·2026
Same author

CSDE1 promotes passenger strand cleavage of miR-486.

RNA biology·2026

Acute myeloid leukemia (AML) is driven by leukemia stem cells (LSC). Xenotransplantation models are crucial for understanding LSC biology and developing targeted AML therapies.

Area of Science:

  • Hematology
  • Cancer Biology
  • Stem Cell Research

Background:

  • Acute myeloid leukemia (AML) is a clonal disorder characterized by abnormal myeloid cell accumulation.
  • Leukemia stem cells (LSC) are believed to perpetuate AML due to their self-renewal capacity.
  • Understanding LSC is vital for deciphering leukemogenesis and designing effective AML treatments.

Purpose of the Study:

  • To review the use of xenotransplantation models in characterizing the nature of the leukemic clone in AML.
  • To highlight advances in phenotypically, molecularly, and functionally defining LSC.
  • To discuss novel AML therapeutics targeting LSC.

Main Methods:

  • Review of xenotransplantation studies in human AML models.
  • Analysis of phenotypic, molecular, and functional characteristics of LSC.

Related Experiment Videos

  • Examination of emerging LSC-directed AML therapies.

    • Main Results:

    • Xenotransplantation models provide a powerful tool for studying human AML in vivo.
    • Significant progress has been made in defining LSC properties using these models.
    • These studies are paving the way for novel therapeutic strategies.

    Conclusions:

    • Xenotransplantation is instrumental in unraveling the complexities of AML pathogenesis.
    • Targeting LSC holds significant promise for eradicating AML.
    • Continued research in this area is essential for improving patient outcomes.